Published in PLoS Med on June 10, 2008
The burden of selected chronic non-communicable diseases and their risk factors in Malawi: nationwide STEPS survey. PLoS One (2011) 3.21
Non-communicable diseases in low- and middle-income countries: context, determinants and health policy. Trop Med Int Health (2008) 2.86
Defining the research agenda to reduce the joint burden of disease from diabetes mellitus and tuberculosis. Trop Med Int Health (2010) 2.35
Effects of smoking and solid-fuel use on COPD, lung cancer, and tuberculosis in China: a time-based, multiple risk factor, modelling study. Lancet (2008) 2.27
A global framework for action to improve the primary care response to chronic non-communicable diseases: a solution to a neglected problem. BMC Public Health (2009) 1.87
Epidemiology and interaction of diabetes mellitus and tuberculosis and challenges for care: a review. Public Health Action (2013) 1.41
The co-management of tuberculosis and diabetes: challenges and opportunities in the developing world. PLoS Med (2012) 1.09
The Effectiveness of Interventions for Non-Communicable Diseases in Humanitarian Crises: A Systematic Review. PLoS One (2015) 0.92
Adapting HIV patient and program monitoring tools for chronic non-communicable diseases in Ethiopia. Global Health (2016) 0.81
High loss to follow-up following obstetric fistula repair surgery in rural Burundi: is there a way forward? Public Health Action (2013) 0.81
Standard case management of asthma in Sudan: a pilot project. Public Health Action (2013) 0.81
Barriers to using eHealth data for clinical performance feedback in Malawi: A case study. Int J Med Inform (2015) 0.76
You can treat my HIV - But can you treat my blood pressure? Availability of integrated HIV and non-communicable disease care in northern Malawi. Afr J Prim Health Care Fam Med (2017) 0.75
A systematic review of primary care models for non-communicable disease interventions in Sub-Saharan Africa. BMC Fam Pract (2017) 0.75
The global burden of chronic diseases: overcoming impediments to prevention and control. JAMA (2004) 8.25
Grand challenges in chronic non-communicable diseases. Nature (2007) 7.86
True outcomes for patients on antiretroviral therapy who are "lost to follow-up" in Malawi. Bull World Health Organ (2007) 6.81
Scaling up antiretroviral treatment in resource-poor settings. Lancet (2006) 5.51
Supervision, monitoring and evaluation of nationwide scale-up of antiretroviral therapy in Malawi. Bull World Health Organ (2006) 4.45
Scaling up antiretroviral therapy in Africa: learning from tuberculosis control programmes--the case of Malawi. Int J Tuberc Lung Dis (2005) 4.04
Stroke mortality in urban and rural Tanzania. Adult Morbidity and Mortality Project. Lancet (2000) 3.53
Noncommunicable diseases in sub-Saharan Africa: where do they feature in the health research agenda? Bull World Health Organ (2001) 3.48
Asleep at the switch: local public health and chronic disease. Am J Public Health (2004) 3.33
Ghana: defining the African challenge. Lancet (2002) 3.08
Deaths from tuberculosis in sub-Saharan African countries with a high prevalence of HIV-1. Lancet (2001) 2.72
Time to right the wrongs: improving basic health care in Nigeria. Lancet (2002) 2.47
Prevalence of stroke survivors in rural South Africa: results from the Southern Africa Stroke Prevention Initiative (SASPI) Agincourt field site. Stroke (2004) 2.22
Ensuring uninterrupted supplies of antiretroviral drugs in resource-poor settings: an example from Malawi. Bull World Health Organ (2007) 2.17
Tanzania: still optimistic after all these years? Lancet (1999) 2.07
Diabetes care in sub-Saharan Africa. Lancet (2006) 1.72
Secondary prevention of stroke--results from the Southern Africa Stroke Prevention Initiative (SASPI) study. Bull World Health Organ (2004) 1.55
Affordability of inhaled corticosteroids as a potential barrier to treatment of asthma in some developing countries. Int J Tuberc Lung Dis (2000) 1.41
What is the best approach to treating schizophrenia in developing countries? PLoS Med (2007) 1.39
Epilepsy in developing countries: a review of epidemiological, sociocultural, and treatment aspects. Epilepsia (1988) 1.38
Principles of IUATLD collaborative tuberculosis progammes. Bull Int Union Tuberc Lung Dis (1991) 1.38
Feasibility of brief tobacco cessation advice for tuberculosis patients: a study from Sudan. Int J Tuberc Lung Dis (2007) 1.25
Implementation of asthma guidelines in health centres of several developing countries. Int J Tuberc Lung Dis (2006) 0.92
Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort. AIDS (2006) 5.13
Prevention of mother-to-child transmission of HIV and the health-related Millennium Development Goals: time for a public health approach. Lancet (2011) 5.00
Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients. PLoS Med (2012) 4.69
XDR tuberculosis: an indicator of public-health negligence. Lancet (2006) 3.91
Electronic medical record systems, data quality and loss to follow-up: survey of antiretroviral therapy programmes in resource-limited settings. Bull World Health Organ (2008) 3.85
The HIV-associated tuberculosis epidemic--when will we act? Lancet (2010) 3.82
Using touchscreen electronic medical record systems to support and monitor national scale-up of antiretroviral therapy in Malawi. PLoS Med (2010) 3.53
WNT1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis. J Clin Invest (2009) 3.33
Unacceptable attrition among WHO stages 1 and 2 patients in a hospital-based setting in rural Malawi: can we retain such patients within the general health system? Trans R Soc Trop Med Hyg (2010) 2.96
Providing universal access to antiretroviral therapy in Thyolo, Malawi through task shifting and decentralization of HIV/AIDS care. Trop Med Int Health (2010) 2.92
Task shifting for antiretroviral treatment delivery in sub-Saharan Africa: not a panacea. Lancet (2008) 2.89
Switching to second-line antiretroviral therapy in resource-limited settings: comparison of programmes with and without viral load monitoring. AIDS (2009) 2.75
Assessing the quality of data aggregated by antiretroviral treatment clinics in Malawi. Bull World Health Organ (2008) 2.62
Monitoring the response to antiretroviral therapy in resource-poor settings: the Malawi model. Trans R Soc Trop Med Hyg (2004) 2.51
Population-level reduction in adult mortality after extension of free anti-retroviral therapy provision into rural areas in northern Malawi. PLoS One (2010) 2.36
Early active follow-up of patients on antiretroviral therapy (ART) who are lost to follow-up: the 'Back-to-Care' project in Lilongwe, Malawi. Trop Med Int Health (2010) 2.28
Strategies to improve patient retention on antiretroviral therapy in sub-Saharan Africa. Trop Med Int Health (2010) 2.19
Outcome assessment of decentralization of antiretroviral therapy provision in a rural district of Malawi using an integrated primary care model. Trop Med Int Health (2010) 2.19
Ensuring uninterrupted supplies of antiretroviral drugs in resource-poor settings: an example from Malawi. Bull World Health Organ (2007) 2.17
In resource-limited settings good early outcomes can be achieved in children using adult fixed-dose combination antiretroviral therapy. AIDS (2006) 2.11
Excellent outcomes among HIV+ children on ART, but unacceptably high pre-ART mortality and losses to follow-up: a cohort study from Cambodia. BMC Pediatr (2009) 2.10
Estimating the need for antiretroviral treatment and an assessment of a simplified HIV/AIDS case definition in rural Malawi. AIDS (2007) 1.93
Scaling up antiretroviral therapy in Malawi-implications for managing other chronic diseases in resource-limited countries. J Acquir Immune Defic Syndr (2009) 1.91
Mortality reduction associated with HIV/AIDS care and antiretroviral treatment in rural Malawi: evidence from registers, coffin sales and funerals. PLoS One (2010) 1.89
A global framework for action to improve the primary care response to chronic non-communicable diseases: a solution to a neglected problem. BMC Public Health (2009) 1.87
Profile: the Karonga Health and Demographic Surveillance System. Int J Epidemiol (2012) 1.85
High prevalence of lipoatrophy among patients on stavudine-containing first-line antiretroviral therapy regimens in Rwanda. Trans R Soc Trop Med Hyg (2007) 1.82
A national survey of teachers on antiretroviral therapy in Malawi: access, retention in therapy and survival. PLoS One (2007) 1.80
Keeping health facilities safe: one way of strengthening the interaction between disease-specific programmes and health systems. Trop Med Int Health (2010) 1.66
Cohort monitoring of persons with hypertension: an illustrated example from a primary healthcare clinic for Palestine refugees in Jordan. Trop Med Int Health (2012) 1.60
Screening of patients with tuberculosis for diabetes mellitus in China. Trop Med Int Health (2012) 1.58
A national survey of the impact of rapid scale-up of antiretroviral therapy on health-care workers in Malawi: effects on human resources and survival. Bull World Health Organ (2007) 1.53
What happens to ART-eligible patients who do not start ART? Dropout between screening and ART initiation: a cohort study in Karonga, Malawi. BMC Public Health (2010) 1.51
Mortality and loss to follow-up in the first year of ART: Malawi national ART programme. AIDS (2012) 1.50
Diagnosis and management of antiretroviral-therapy failure in resource-limited settings in sub-Saharan Africa: challenges and perspectives. Lancet Infect Dis (2010) 1.47
Stavudine- and nevirapine-related drug toxicity while on generic fixed-dose antiretroviral treatment: incidence, timing and risk factors in a three-year cohort in Kigali, Rwanda. Trans R Soc Trop Med Hyg (2009) 1.47
Gender differences in retention and survival on antiretroviral therapy of HIV-1 infected adults in Malawi. Malawi Med J (2010) 1.46
Comparison of treatment outcomes of new smear-positive pulmonary tuberculosis patients by HIV and antiretroviral status in a TB/HIV clinic, Malawi. PLoS One (2013) 1.43
Individual, household and community factors associated with HIV test refusal in rural Malawi. Trop Med Int Health (2008) 1.41
Different delivery models for antiretroviral therapy in sub-Saharan Africa in the context of 'universal access'. Trans R Soc Trop Med Hyg (2008) 1.40
Adult mortality and probable cause of death in rural northern Malawi in the era of HIV treatment. Trop Med Int Health (2012) 1.38
Outcomes of TB treatment by HIV status in national recording systems in Brazil, 2003-2008. PLoS One (2012) 1.37
Ethics of conducting research in conflict settings. Confl Health (2009) 1.34
Treatment outcomes stratified by baseline immunological status among young children receiving nonnucleoside reverse-transcriptase inhibitor-based antiretroviral therapy in resource-limited settings. Clin Infect Dis (2007) 1.34
Ebola outbreak in rural West Africa: epidemiology, clinical features and outcomes. Trop Med Int Health (2015) 1.33
Are they really lost? "true" status and reasons for treatment discontinuation among HIV infected patients on antiretroviral therapy considered lost to follow up in Urban Malawi. PLoS One (2013) 1.32
Screening patients with diabetes mellitus for tuberculosis in China. Trop Med Int Health (2012) 1.27
Is Option B+ the best choice? Lancet (2013) 1.24
The vital signs of chronic disease management. Trans R Soc Trop Med Hyg (2009) 1.24
Cohort monitoring of persons with diabetes mellitus in a primary healthcare clinic for Palestine refugees in Jordan. Trop Med Int Health (2012) 1.23
Antiretroviral drug supply challenges in the era of scaling up ART in Malawi. J Int AIDS Soc (2011) 1.22
HIV and tuberculosis--science and implementation to turn the tide and reduce deaths. J Int AIDS Soc (2012) 1.21
Assessment of clofazimine activity in a second-line regimen for tuberculosis in mice. Am J Respir Crit Care Med (2013) 1.20
High survival and treatment success sustained after two and three years of first-line ART for children in Cambodia. J Int AIDS Soc (2010) 1.18
The angiotensin II receptor 2 is expressed and mediates angiotensin II signaling in lung fibrosis. Am J Respir Cell Mol Biol (2007) 1.15
Abolishing user fees for children and pregnant women trebled uptake of malaria-related interventions in Kangaba, Mali. Health Policy Plan (2011) 1.14
Incidence of pregnancy among women accessing antiretroviral therapy in urban Malawi: a retrospective cohort study. AIDS Behav (2013) 1.10
Prevalence of HIV drug resistance before and 1 year after treatment initiation in 4 sites in the Malawi antiretroviral treatment program. Clin Infect Dis (2012) 1.10
Improving data quality and supervision of antiretroviral therapy sites in Malawi: an application of Lot Quality Assurance Sampling. BMC Health Serv Res (2012) 1.08
No cash, no care: how user fees endanger health--lessons learnt regarding financial barriers to healthcare services in Burundi, Sierra Leone, Democratic Republic of Congo, Chad, Haiti and Mali. Int Health (2011) 1.08
Evaluation of four rapid tests for diagnosis and differentiation of HIV-1 and HIV-2 infections in Guinea-Conakry, West Africa. Trans R Soc Trop Med Hyg (2010) 1.07
Safety, effectiveness, and outcomes of concomitant use of highly active antiretroviral therapy with drugs for tuberculosis in resource-poor settings. Lancet (2006) 1.05
The timing of death in patients with tuberculosis who die during anti-tuberculosis treatment in Andhra Pradesh, South India. BMC Public Health (2011) 1.02
Bacterial meningitis in Malawian adults, adolescents, and children during the era of antiretroviral scale-up and Haemophilus influenzae type b vaccination, 2000-2012. Clin Infect Dis (2014) 1.02
High prevalence of tuberculosis and insufficient case detection in two communities in the Western Cape, South Africa. PLoS One (2013) 1.01
Reliability and accuracy of the South African Triage Scale when used by nurses in the emergency department of Timergara Hospital, Pakistan. S Afr Med J (2014) 1.01
Providing emergency care and assessing a patient triage system in a referral hospital in Somaliland: a cross-sectional study. BMC Health Serv Res (2014) 1.01
Implication of new WHO growth standards on identification of risk factors and estimated prevalence of malnutrition in rural Malawian infants. PLoS One (2008) 1.01
Short and long term retention in antiretroviral care in health facilities in rural Malawi and Zimbabwe. BMC Health Serv Res (2012) 0.98
jCompoundMapper: An open source Java library and command-line tool for chemical fingerprints. J Cheminform (2011) 0.98
Antiretroviral therapy in the Malawi defence force: access, treatment outcomes and impact on mortality. PLoS One (2008) 0.96
Treatment outcomes in a cohort of Palestine refugees with diabetes mellitus followed through use of E-Health over 3 years in Jordan. Trop Med Int Health (2013) 0.96
Use of antenatal clinic surveillance to assess the effect of sexual behavior on HIV prevalence in young women in Karonga district, Malawi. J Acquir Immune Defic Syndr (2008) 0.96
How operational research influenced the scale up of antiretroviral therapy in Malawi. Health Care Manag Sci (2011) 0.95
High prevalence of tuberculosis and serious bloodstream infections in ambulatory individuals presenting for antiretroviral therapy in Malawi. PLoS One (2012) 0.95
Re-treatment tuberculosis cases categorised as "other": are they properly managed? PLoS One (2011) 0.94
Timing of antiretroviral therapy and regimen for HIV-infected patients with tuberculosis: the effect of revised HIV guidelines in Malawi. BMC Public Health (2014) 0.94
Six-month mortality among HIV-infected adults presenting for antiretroviral therapy with unexplained weight loss, chronic fever or chronic diarrhea in Malawi. PLoS One (2012) 0.93
Obstetric fistula in Burundi: a comprehensive approach to managing women with this neglected disease. BMC Pregnancy Childbirth (2013) 0.92
Operational research in Malawi: making a difference with cotrimoxazole preventive therapy in patients with tuberculosis and HIV. BMC Public Health (2011) 0.92
Simplifying ART cohort monitoring: can pharmacy stocks provide accurate estimates of patients retained on antiretroviral therapy in Malawi? BMC Health Serv Res (2012) 0.92
Interpreting linear support vector machine models with heat map molecule coloring. J Cheminform (2011) 0.91
Brief Report: HIV Testing Among Pregnant Women Who Attend Antenatal Care in Malawi. J Acquir Immune Defic Syndr (2015) 0.90
Use of support vector machines for disease risk prediction in genome-wide association studies: concerns and opportunities. Hum Mutat (2012) 0.89
An appraisal of indicators used to monitor the treated population in antiretroviral programmes in low-income countries. AIDS (2010) 0.88
Is mid-upper arm circumference alone sufficient for deciding admission to a nutritional programme for childhood severe acute malnutrition in Bangladesh? Trans R Soc Trop Med Hyg (2013) 0.88
Atomic local neighborhood flexibility incorporation into a structured similarity measure for QSAR. J Chem Inf Model (2009) 0.87
Baseline characteristics, response to and outcome of antiretroviral therapy among patients with HIV-1, HIV-2 and dual infection in Burkina Faso. Trans R Soc Trop Med Hyg (2009) 0.87
Very early anthropometric changes after antiretroviral therapy predict subsequent survival, in karonga, Malawi. Open AIDS J (2012) 0.87
The journey to antiretroviral therapy in Karnataka, India: who was lost on the road? J Int AIDS Soc (2013) 0.86
A national survey of prisoners on antiretroviral therapy in Malawi: access to treatment and outcomes on therapy. J Infect Dev Ctries (2007) 0.86
Controlled self-assembly of monodisperse niosomes by microfluidic hydrodynamic focusing. Langmuir (2010) 0.85
Facing up to programmatic challenges created by the HIV/AIDS epidemic in sub-Saharan Africa. J Int AIDS Soc (2011) 0.85
Transcriptional regulation by BglJ-RcsB, a pleiotropic heteromeric activator in Escherichia coli. Nucleic Acids Res (2013) 0.83